Immunovant, Inc. (NASDAQ: IMVT) Stock Price & Quote

Live IMVT stock price and quote for Immunovant, Inc., listed on the Nasdaq Stock Market under the ticker symbol IMVT. This page shows the current Immunovantshare price, today's change, an interactive price chart, key statistics and full financial statements.

Immunovant stock price today (IMVT)

Track the IMVT price in real time: last traded price, change and percent change on the day, open, previous close, day range, and the 52-week high and low for Immunovant, Inc..

IMVT key statistics

Market capitalisation, price-to-earnings (P/E) ratio, trailing twelve month earnings per share, dividend and dividend yield, beta, shares outstanding, average daily volume and the next earnings date for Immunovant.

Immunovant financial statements

Annual (10-K) and quarterly (10-Q) income statement, balance sheet and cash flow statement for Immunovant, Inc. (NASDAQ: IMVT), drawn from filings.

Where does Immunovant trade?

Immunovant, Inc. trades on the Nasdaq Stock Market under the symbol IMVT. The quote page for this security is https://themarketisopen.com/stock/price/quote/NASDAQ/IMVT.

Compare and discuss IMVT

Mkts

18 years of quarterly financials. Every ticker. Free.

Search 12,500+ stocks and ETFs for live quotes and interactive charts - then read the full income statement, balance sheet and cash flow, up to 71 quarters deep, chart any line item, and export it to CSV - the data the other sites charge for, or never show at all.

Popular:
12,581
Stocks & ETFs, searchable
9,185
Stocks with full financial statements
71 quarters
Deepest quarterly history

Arcade

Six market games. Free, no sign-up.

Prefer to browse? Every listing by exchange and letter.

Tap a stock to open it here

Pick one from your list below, or search above — everything about that company opens right here on this page.

  • Live quote
  • Interactive chart
  • Key statistics
  • Community thread
  • Ticker news
  • 18 years of financials

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…